Skip to content

Opening book details…

About this Medicine article

Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial by Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles Montalescot; Mingyuan Shao; Werner Hacke; Keith A. Fox; Peter B. Berger; Eric J. Topol; A. Michael Lincoff is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles Montalescot; Mingyuan Shao; Werner Hacke; Keith A. Fox; Peter B. Berger; Eric J. Topol; A. Michael Lincoff
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6744)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles Montalescot; Mingyuan Shao; Werner Hacke; Keith A. Fox; Peter B. Berger; Eric J. Topol; A. Michael Lincoff

Browse all works by Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles Montalescot; Mingyuan Shao; Werner Hacke; Keith A. Fox; Peter B. Berger; Eric J. Topol; A. Michael Lincoff